{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:31Z","timestamp":1791644251422,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]},{"name":"Medical Research Agency, Poland","award":["No: 2020\/ABM\/01\/00014-00"],"award-info":[{"award-number":["No: 2020\/ABM\/01\/00014-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40196-0","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:28:53Z","timestamp":1772180933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug discovery"],"prefix":"10.1038","volume":"16","author":[{"given":"Emilia","family":"Sinderewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"D\u0105bkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sarnowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Staszkiewicz-Chodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Mystkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Holak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Drozd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chodkowska-Michalowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Rytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Paczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin P.","family":"Mycko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Machalinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Jezierska-Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"40196_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cge.12117","volume":"83","author":"M Sabatelli","year":"2013","unstructured":"Sabatelli, M., Conte, A. & Zollino, M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin. Genet. 83, 408\u2013416 (2013).","journal-title":"Clin. Genet."},{"key":"40196_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/14653240802549470","volume":"11","author":"H Deda","year":"2009","unstructured":"Deda, H. et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: A 1-year follow-up. Cytotherapy 11, 18\u201325 (2009).","journal-title":"Cytotherapy"},{"key":"40196_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","volume":"79","author":"S Witzel","year":"2022","unstructured":"Witzel, S. et al. Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis. JAMA Neurol. 79, 121\u2013130 (2022).","journal-title":"JAMA Neurol."},{"key":"40196_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"40196_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-016-0289-5","volume":"23","author":"LT Wang","year":"2016","unstructured":"Wang, L. T. et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: Review of current clinical trials. J. Biomed. Sci. 23, 76 (2016).","journal-title":"J. Biomed. Sci."},{"key":"40196_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainresbull.2023.01.008","volume":"194","author":"F Sironi","year":"2023","unstructured":"Sironi, F., De Marchi, F., Mazzini, L. & Bendotti, C. Cell therapy in ALS: An update on preclinical and clinical studies. Brain Res. Bull. 194, 64\u201381 (2023).","journal-title":"Brain Res. Bull."},{"key":"40196_CR7","first-page":"413","volume":"21","author":"Y Ciervo","year":"2021","unstructured":"Ciervo, Y. et al. Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS. Mol. Ther. 21, 413\u2013433 (2021).","journal-title":"Mol. Ther."},{"key":"40196_CR8","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/cne.23575","volume":"522","author":"D Dolezalova","year":"2014","unstructured":"Dolezalova, D. et al. Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies. J. Comp. Neurol. 522, 2784\u20132801 (2014).","journal-title":"J. Comp. Neurol."},{"key":"40196_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00377-7","volume":"12","author":"L Zhu","year":"2023","unstructured":"Zhu, L., Li, S., Li, X. J. & Yin, P. Pathological insights from amyotrophic lateral sclerosis animal models: Comparisons, limitations, and challenges. Transl. Neurodegener. 12, 46 (2023).","journal-title":"Transl. Neurodegener."},{"key":"40196_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nbd.2018.11.021","volume":"124","author":"P Crociara","year":"2019","unstructured":"Crociara, P. et al. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS. Neurobiol. Dis. 124, 263\u2013275 (2019).","journal-title":"Neurobiol. Dis."},{"key":"40196_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/cr.2014.25","volume":"24","author":"H Yang","year":"2014","unstructured":"Yang, H. et al. Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res. 24, 464\u2013481 (2014).","journal-title":"Cell Res."},{"key":"40196_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106729","volume":"86","author":"B Zhang","year":"2020","unstructured":"Zhang, B. et al. DL0410 attenuates oxidative stress and neuroinflammation via BDNF\/TrkB\/ERK\/CREB and Nrf2\/HO-1 activation. Int. Immunopharmacol. 86, 106729 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"40196_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/jnc.15617","volume":"161","author":"S Ateaque","year":"2022","unstructured":"Ateaque, S. et al. Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC. J. Neurochem. 161, 463\u2013477 (2022).","journal-title":"J. Neurochem."},{"key":"40196_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","volume":"52","author":"The BDNF Study Group","year":"1999","unstructured":"The BDNF Study Group. A controlled trial of Recombinant methionyl human BDNF in ALS: the BDNF study group (Phase III). Neurology 52, 1427\u20131433 (1999).","journal-title":"Neurology"},{"key":"40196_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45045-y","volume":"13","author":"M D\u0105bkowska","year":"2023","unstructured":"D\u0105bkowska, M. et al. BDNF-loaded PDADMAC-heparin multilayers: A novel approach for neuroblastoma cell study. Sci. Rep. 13, 17939 (2023).","journal-title":"Sci. Rep."},{"key":"40196_CR16","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/pharmaceutics15092236","volume":"15","author":"M D\u0105bkowska","year":"2023","unstructured":"D\u0105bkowska, M., Kosiorowska, A. & Machali\u0144ski, B. The impact of serum protein adsorption on pegylated NT3-BDNF nanoparticles\u2013distribution, protein release, and cytotoxicity in a human retinal pigmented epithelial cell model. Pharmaceutics 15, 2236 (2023).","journal-title":"Pharmaceutics"},{"key":"40196_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130726","volume":"265","author":"M D\u0105bkowska","year":"2024","unstructured":"D\u0105bkowska, M. et al. In vitro and in vivo characterization of human serum albumin-based PEGylated nanoparticles for BDNF and NT3 codelivery. Int. J. Biol. Macromol. 265, 130726 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"40196_CR18","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.2174\/1570159X22666240509092903","volume":"22","author":"XY Song","year":"2024","unstructured":"Song, X. Y., Fan, C. X., Rahman, A. U., Choudhary, M. I. & Wang, X. P. Neuro-regeneration or repair: Cell therapy of neurological disorders as a way forward. Curr. Neuropharmacol. 22, 2272\u20132283 (2024).","journal-title":"Curr. Neuropharmacol."},{"key":"40196_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031254","volume":"7","author":"S Garbuzova-Davis","year":"2012","unstructured":"Garbuzova-Davis, S. et al. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One 7, e31254 (2012).","journal-title":"PLoS One"},{"key":"40196_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002494","volume":"3","author":"S Garbuzova-Davis","year":"2008","unstructured":"Garbuzova-Davis, S. et al. Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose. PLoS One 3, e2494 (2008).","journal-title":"PLoS One"},{"key":"40196_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/jnr.23368","volume":"92","author":"T Terashima","year":"2014","unstructured":"Terashima, T. et al. Stem cell factor-activated bone marrow ameliorates amyotrophic lateral sclerosis by promoting protective microglial migration. J. Neurosci. Res. 92, 856\u2013869 (2014).","journal-title":"J. Neurosci. Res."},{"key":"40196_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13543784.2019.1627324","volume":"28","author":"SA Goutman","year":"2019","unstructured":"Goutman, S. A., Savelieff, M. G., Sakowski, S. A. & Feldman, E. L. Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials. Expert Opin. Investig. Drugs 28, 525\u2013543 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"40196_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.1628","volume":"32","author":"JS Lunn","year":"2014","unstructured":"Lunn, J. S., Sakowski, S. A. & Feldman, E. L. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future. Stem Cells 32, 1099\u20131109 (2014).","journal-title":"Stem Cells"},{"key":"40196_CR24","doi-asserted-by":"crossref","unstructured":"Atassi, N. et al. attendees of the International Workshop on Progress in Stem Cells Research for ALS\/MND. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: ready for efficacy clinical trials? Cytotherapy 18, 1471\u20131475 (2016).","DOI":"10.1016\/j.jcyt.2016.08.005"},{"key":"40196_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.24113","volume":"75","author":"EL Feldman","year":"2014","unstructured":"Feldman, E. L. et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes. Ann. Neurol. 75, 363\u2013373 (2014).","journal-title":"Ann. Neurol."},{"key":"40196_CR26","doi-asserted-by":"crossref","unstructured":"Kuzma-Kozakiewicz, M. et al. Intraspinal transplantation of the adipose tissue-derived regenerative cells in amyotrophic lateral sclerosis in accordance with the current experts\u2019 recommendations: choosing optimal monitoring tools. Stem Cells Int. 4392017 (2018). (2018).","DOI":"10.1155\/2018\/4392017"},{"key":"40196_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/sctm.18-0154","volume":"8","author":"L Mazzini","year":"2019","unstructured":"Mazzini, L. et al. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: A long-term outcome. Stem Cells Transl. Med. 8, 887\u2013897 (2019).","journal-title":"Stem Cells Transl. Med."},{"key":"40196_CR28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12015-020-10016-7","volume":"16","author":"M Barczewska","year":"2020","unstructured":"Barczewska, M. et al. Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: An original study. Stem Cell Rev. Rep. 16, 922\u2013932 (2020).","journal-title":"Stem Cell Rev. Rep."},{"key":"40196_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.52586\/4980","volume":"26","author":"P Petrou","year":"2021","unstructured":"Petrou, P., Kassis, I., Yaghmour, N. E., Ginzberg, A. & Karussis, D. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front. Biosci. Landmark 26, 693\u2013706 (2021).","journal-title":"Front. Biosci. Landmark"},{"key":"40196_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1227\/NEU.0000000000000156","volume":"74","author":"J Riley","year":"2014","unstructured":"Riley, J. et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: A phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery 74, 77\u201387 (2014).","journal-title":"Neurosurgery"},{"key":"40196_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","volume":"67","author":"D Karussis","year":"2010","unstructured":"Karussis, D. et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67, 1187\u20131194 (2010).","journal-title":"Arch. Neurol."},{"key":"40196_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/0028-3886.103185","volume":"60","author":"S Prabhakar","year":"2012","unstructured":"Prabhakar, S. et al. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: A pilot study. Neurol. India 60, 465\u2013469 (2012).","journal-title":"Neurol. India"},{"key":"40196_CR33","first-page":"592","volume":"20","author":"SM Nabavi","year":"2019","unstructured":"Nabavi, S. M. et al. Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow-derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase I clinical trial. Cell. J. 20, 592\u2013598 (2019).","journal-title":"Cell. J."},{"key":"40196_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/1673-5374.243723","volume":"14","author":"M Barczewska","year":"2019","unstructured":"Barczewska, M. et al. Safety of intrathecal injection of Wharton\u2019s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy. Neural Regen. Res. 14, 313\u2013318 (2019).","journal-title":"Neural Regen. Res."},{"key":"40196_CR35","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","volume":"87","author":"NP Staff","year":"2016","unstructured":"Staff, N. P. et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology 87, 2230\u20132234 (2016).","journal-title":"Neurology"},{"key":"40196_CR36","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","volume":"93","author":"JD Berry","year":"2019","unstructured":"Berry, J. D. et al. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology 93, e2294\u2013e2305 (2019).","journal-title":"Neurology"},{"key":"40196_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020845","volume":"22","author":"S Shin","year":"2021","unstructured":"Shin, S. et al. Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton\u2019s jelly. Int. J. Mol. Sci. 22, 845. https:\/\/doi.org\/10.3390\/ijms22020845 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"40196_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5966\/sctm.2014-0212","volume":"4","author":"KW Oh","year":"2015","unstructured":"Oh, K. W. et al. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl. Med. 4, 590\u2013597 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"40196_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.27472","volume":"65","author":"ME Cudkowicz","year":"2022","unstructured":"Cudkowicz, M. E. et al. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve 65, 291\u2013302 (2022).","journal-title":"Muscle Nerve"},{"key":"40196_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.mri.2010.03.047","volume":"28","author":"TH Kim","year":"2010","unstructured":"Kim, T. H. et al. Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI. Magn. Reson. Imaging 28, 1004\u20131013 (2010).","journal-title":"Magn. Reson. Imaging"},{"key":"40196_CR41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1148\/radiol.2283020322","volume":"228","author":"HE Daldrup-Link","year":"2003","unstructured":"Daldrup-Link, H. E. et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228, 760\u2013767 (2003).","journal-title":"Radiology"},{"key":"40196_CR42","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1161\/01.CIR.0000070931.62772.4E","volume":"107","author":"DL Kraitchman","year":"2003","unstructured":"Kraitchman, D. L. et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290\u20132293 (2003).","journal-title":"Circulation"},{"key":"40196_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/radiol.2381041668","volume":"238","author":"O Hauger","year":"2006","unstructured":"Hauger, O. et al. W. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 238, 200\u2013210 (2006).","journal-title":"Radiology"},{"key":"40196_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13287-018-1123-7","volume":"10","author":"H Markides","year":"2019","unstructured":"Markides, H. et al. Ex vivo MRI cell tracking of autologous mesenchymal stromal cells in a bovine osteochondral defect model. Stem Cell. Res. Ther. 10, 25 (2019).","journal-title":"Stem Cell. Res. Ther."},{"key":"40196_CR45","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1021\/ja1084095","volume":"133","author":"T Kim","year":"2011","unstructured":"Kim, T. et al. Mesoporous silica-coated Hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 133, 2955\u20132961 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"40196_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0024-3205(00)00602-0","volume":"67","author":"N Ende","year":"2000","unstructured":"Ende, N., Weinstein, F., Chen, R. & Ende, M. Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci. 67, 53\u201359 (2000).","journal-title":"Life Sci."},{"key":"40196_CR47","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00702-007-0748-y","volume":"114","author":"HJ Habisch","year":"2007","unstructured":"Habisch, H. J. et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J. Neural Transm (Vienna). 114, 1395\u20131406 (2007).","journal-title":"J. Neural Transm (Vienna)"},{"key":"40196_CR48","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.2147\/IJN.S210140","volume":"14","author":"M D\u0105bkowska","year":"2019","unstructured":"D\u0105bkowska, M. et al. Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo. Int. J. Nanomed. 14, 6117\u20136131 (2019).","journal-title":"Int. J. Nanomed."},{"key":"40196_CR49","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1021\/acs.langmuir.7b00909","volume":"33","author":"M D\u0105bkowska","year":"2017","unstructured":"D\u0105bkowska, M., Adamczak, M., Barbasz, J., Cie\u015bla, M. & Machali\u0144ski, B. Adsorption\/desorption transition of recombinant human neurotrophin 4: Physicochemical characterization. Langmuir 33, 9548\u20139557 (2017).","journal-title":"Langmuir"},{"key":"40196_CR50","doi-asserted-by":"publisher","unstructured":"D\u0105bkowska, M.; Adamczyk, Z.; Cie\u015bla, M.; Adamczak, M.; Bober, J. Lysozyme Monolayers at Polymer Microparticles:Electrokinetic Characteristics and Modeling. J. Phys. Chem. C 2018, 122 (36), 20777\u201320788. DOI:https:\/\/doi.org\/10.1021\/acs.jpcc.8b04916.","DOI":"10.1021\/acs.jpcc.8b04916"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40196-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:02:13Z","timestamp":1775124133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40196-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40196"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40196-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7641255\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11216"}}